Brachytherapy training survey among radiation oncology residents in Europe.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
12 2022
Historique:
received: 10 07 2022
revised: 03 10 2022
accepted: 23 10 2022
pubmed: 4 11 2022
medline: 21 12 2022
entrez: 3 11 2022
Statut: ppublish

Résumé

We aim to investigate the current state of brachytherapy (BT) training among the radiation oncology trainees in Europe. A 22-question online survey based on the one by the American Association of Radiation Oncology Residents (2017) with added queries pertinent to training in Europe was sent to 1450 residents in two iterations. These included site-specific training, volume of experience, barriers to training, institutional support, and preferences for further education. Responses to individual statements were given on a 1 to 5 Likert-type scale. The answers were reported by junior (≤3 years of training) and senior years of training (year of training 4/5/6 and junior staff). Descriptive statistics were used to describe frequencies. Residents from 21 European countries participated, 445 (31%) responded. 205 (47%) were senior residents. 60% residents consider that performing BT independently at the end of residency is very or somewhat important. Confidence in joining a brachytherapy practice at the end of residency was high or somewhat high in 34% of senior residents. They reported as barriers to achieving independence in BT to be lack of appropriate didactic/procedural training from supervisors (47%) and decreased case load (31%). 68% reported their program lacks a formal BT curriculum and standardized training assessment. Residents in Europe, feel independent BT practice is very or somewhat important, but do not feel confident they will achieve this goal. To address this gap, efforts are needed to develop and implement a formal and comprehensive BT curriculum with easy access to trained instructors.

Identifiants

pubmed: 36328092
pii: S0167-8140(22)04525-X
doi: 10.1016/j.radonc.2022.10.030
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

172-178

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Alina Emiliana Sturdza (AE)

Medical University of Vienna, Department of Radiation Oncology, Comprehensive Cancer Center, Vienna, Austria.

Marianne Stephanides (M)

Medical University of Vienna, Department of Statistics, Vienna, Austria.

Ina Jurgenliemk-Schulz (I)

University Medical Center Utrecht, Department of Radiation Oncology, Utrecht, Netherlands.

Jesper Grau Eriksen (JG)

Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark.

Kim Benstead (K)

Gloucestershire NHS Foundation Trust, Gloucester, United Kingdom.

Peter Hoskin (P)

Mount Vernon Cancer Centre, London, and Division of Cancer Sciences, University of Manchester, United Kingdom.

Stefanel Vlad (S)

Neolife Bucuresti - Enayati Medical City, Bucharest, Romania.

Alexandre Escande (A)

University of Lille, Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center, Lille, France.

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Johannes Knoth (J)

Medical University of Vienna, Department of Radiation Oncology, Comprehensive Cancer Center, Vienna, Austria.

Henrike Westerveld (H)

Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, Netherlands.

Luca Tagliaferri (L)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Dina Najari-Jamali (D)

Institut Català d'Oncologia (ICO), Barcelona, Spain.

Katarzyna Konat-Baska (K)

Wroclaw Comprehensive Cancer Center, Department of Oncology, Wroclaw Medical University, Poland.

Vesna Plesinac (V)

Department of Radiation Oncology, Belgrad, Serbia.

Li Tee Tan (LT)

Cambridge University Addenbrooke's Hospital, Department of Clinical Oncology, Cambridge, United Kingdom.

Remi Nout (R)

Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, Netherlands.

Vratislav Strnad (V)

Dept. of Radiation Oncology, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.

Peter Niehoff (P)

Sana Klinikum Offenbach GmbH, Starkenburgring 66, 63069 Offenbach am Main, University Witten - Herdecke, Germany.

Bradley R Pieters (BR)

Department of Radiation Oncology, Amsterdam University Medical Centers/University of Amsterdam, Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Netherlands.

Kari Tanderup (K)

Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark.

Mitchell Kamrava (M)

Department of Radiation Oncology, Cedars-Sinai Medical Center, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH